Stochastic Virtual Population of Subjects With Type 1 Diabetes for the Assessment of Closed-Loop Glucose Controllers

Closed-loop glucose control is an emerging treatment approach to manage type 1 diabetes. Closed-loop systems consist of a continuous glucose monitor, an insulin infusion pump, and a dosing algorithm that directs insulin delivery based on sensor levels. Testing of dosing algorithms in computer simulations may replace animal testing, accelerates development, and saves resources. We propose here a novel approach to generate a virtual population, to be used in metabolic simulators, from routine experimental data through the process that we term “stochastic e-cloning.” We build on a nonlinear physiologically motivated time-varying model of glucose regulation. We adopt the Bayesian approach to estimate model parameters and to obtain the joint posterior probability distribution of time-invariant and time-varying parameters with the use of the Markov chain Monte Carlo methodology. The estimation process combines prior knowledge and experimental data to generate a sample from the posterior distribution, which can be subsequently used to conduct in silico experiments reflecting population and individual variability, and associated uncertainty as closely as possible. The approach is exemplified using data collected in 12 young subjects with type 1 diabetes. We demonstrate unbiased fit to the data, physiological plausibility of parameter estimates, and results of in silico testing using a stochastic virtual subject.

[1]  Claudio Cobelli,et al.  Use of a novel triple-tracer approach to assess postprandial glucose metabolism. , 2003, American journal of physiology. Endocrinology and metabolism.

[2]  J. Stockman,et al.  Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study , 2011 .

[3]  J. Stockman,et al.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2011 .

[4]  Ronald Brazg,et al.  FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart Algorithm, a 1-Hour Warm-up Time , 2011, Journal of diabetes science and technology.

[5]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[6]  K. Strimmer,et al.  Statistical Applications in Genetics and Molecular Biology A Shrinkage Approach to Large-Scale Covariance Matrix Estimation and Implications for Functional Genomics , 2011 .

[7]  R. Hovorka,et al.  Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. , 2002, American journal of physiology. Endocrinology and metabolism.

[8]  Roman Hovorka,et al.  Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes , 2010, Journal of diabetes science and technology.

[9]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[10]  G. Steil,et al.  Effect of Age of Infusion Site and Type of Rapid-Acting Analog on Pharmacodynamic Parameters of Insulin Boluses in Youth With Type 1 Diabetes Receiving Insulin Pump Therapy , 2009, Diabetes Care.

[11]  Claudio Cobelli,et al.  The Effect of Walking on Postprandial Glycemic Excursion in Patients With Type 1 Diabetes and Healthy People , 2012, Diabetes Care.

[12]  Malgorzata E. Wilinska,et al.  Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin , 2005, IEEE Transactions on Biomedical Engineering.

[13]  Roman Hovorka,et al.  Closing the loop: the adicol experience. , 2004, Diabetes technology & therapeutics.

[14]  Malgorzata E. Wilinska,et al.  Evaluation of glucose controllers in virtual environment: methodology and sample application , 2004, Artif. Intell. Medicine.

[15]  Ewart R. Carson,et al.  The mathematical modeling of metabolic and endocrine systems : model formulation, identification, and validation , 1983 .

[16]  R. Hovorka,et al.  Absorption patterns of meals containing complex carbohydrates in type 1 diabetes , 2013, Diabetologia.

[17]  G. Steil,et al.  The Identifiable Virtual Patient Model: Comparison of Simulation and Clinical Closed-Loop Study Results , 2012, Journal of diabetes science and technology.

[18]  Janet M. Allen,et al.  Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies , 2011, BMJ : British Medical Journal.

[19]  Peter Congdon Bayesian statistical modelling , 2002 .

[20]  Garry M. Steil,et al.  Identification of Intraday Metabolic Profiles during Closed-Loop Glucose Control in Individuals with Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[21]  H. Mortensen,et al.  Findings from the Hvidøre Study Group on Childhood Diabetes: Metabolic Control and Quality of Life1 , 2004, Hormone Research in Paediatrics.

[22]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[23]  Roman Hovorka,et al.  Closed-loop insulin delivery: from bench to clinical practice , 2011, Nature Reviews Endocrinology.

[24]  J. Shaw,et al.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. , 2011, Diabetes research and clinical practice.

[25]  John A Todd,et al.  Etiology of type 1 diabetes. , 2010, Immunity.

[26]  Andrew Thomas,et al.  WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..